Siyu Chen1, Eric M Moult1, Linda M Zangwill2, Robert N Weinreb2, James G Fujimoto3. 1. Department of Electrical Engineering and Computer Science, and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. 2. Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and the Shiley Eye Institute, University of California, San Diego, San Diego, California, USA. 3. Department of Electrical Engineering and Computer Science, and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Electronic address: jgfuji@mit.edu.
Abstract
PURPOSE: To develop geometric perfusion deficits (GPD), an optical coherence tomography angiography (OCTA) biomarker based on oxygen diffusion, and to evaluate its utility in a pilot study of healthy subjects and patients with diabetic retinopathy (DR). DESIGN: Retrospective cross-sectional study. METHODS: Commercial spectral-domain optical coherence tomography angiography (OCTA) instruments were used to acquire repeated 3 × 3-mm2 and 6 × 6-mm2 motion-corrected macular OCTA volumes. En face OCTA images corresponding to the superficial capillary plexus (SCP), deep capillary plexus (DCP), and full retinal projections were obtained using automatic segmentation. For each projection, the GPD percentage and the vessel density percentage, the control metric, were computed, and their values were compared between the normal and DR eyes. The repeated OCTA acquisitions were used to assess the test-retest repeatability of the GPD and vessel density percentages. RESULTS: Repeated OCTA scans of 15 normal eyes and 12 DR eyes were obtained. For all en face projections, GPD percentages were significantly higher in DR eyes than in normal eyes; vessel density percentages were significantly lower in all but 1 projection (DCP). Large GPD areas were used to identify focal perfusion deficits. Test-retest analysis showed that the GPD percentage had superior repeatability than the vessel density percentage in most cases. A strong negative correlation between the GPD percentage and the vessel density percentage was also found. CONCLUSIONS: Geometric perfusion deficits, an OCTA biomarker based on oxygen diffusion, provides a quantitative metric of macular microvascular remodeling with a strong physiological underpinning. The GPD percentage may serve as a useful biomarker for detecting and monitoring DR.
PURPOSE: To develop geometric perfusion deficits (GPD), an optical coherence tomography angiography (OCTA) biomarker based on oxygen diffusion, and to evaluate its utility in a pilot study of healthy subjects and patients with diabetic retinopathy (DR). DESIGN: Retrospective cross-sectional study. METHODS: Commercial spectral-domain optical coherence tomography angiography (OCTA) instruments were used to acquire repeated 3 × 3-mm2 and 6 × 6-mm2 motion-corrected macular OCTA volumes. En face OCTA images corresponding to the superficial capillary plexus (SCP), deep capillary plexus (DCP), and full retinal projections were obtained using automatic segmentation. For each projection, the GPD percentage and the vessel density percentage, the control metric, were computed, and their values were compared between the normal and DR eyes. The repeated OCTA acquisitions were used to assess the test-retest repeatability of the GPD and vessel density percentages. RESULTS: Repeated OCTA scans of 15 normal eyes and 12 DR eyes were obtained. For all en face projections, GPD percentages were significantly higher in DR eyes than in normal eyes; vessel density percentages were significantly lower in all but 1 projection (DCP). Large GPD areas were used to identify focal perfusion deficits. Test-retest analysis showed that the GPD percentage had superior repeatability than the vessel density percentage in most cases. A strong negative correlation between the GPD percentage and the vessel density percentage was also found. CONCLUSIONS: Geometric perfusion deficits, an OCTA biomarker based on oxygen diffusion, provides a quantitative metric of macular microvascular remodeling with a strong physiological underpinning. The GPD percentage may serve as a useful biomarker for detecting and monitoring DR.
Authors: Steven A Agemy; Nicole K Scripsema; Chirag M Shah; Toco Chui; Patricia M Garcia; Jessica G Lee; Ronald C Gentile; Yi-Sing Hsiao; Qienyuan Zhou; Tony Ko; Richard B Rosen Journal: Retina Date: 2015-11 Impact factor: 4.256
Authors: Julia Schottenhamml; Eric M Moult; Stefan Ploner; ByungKun Lee; Eduardo A Novais; Emily Cole; Sabin Dang; Chen D Lu; Lennart Husvogt; Nadia K Waheed; Jay S Duker; Joachim Hornegger; James G Fujimoto Journal: Retina Date: 2016-12 Impact factor: 4.256
Authors: Yali Jia; Steven T Bailey; Thomas S Hwang; Scott M McClintic; Simon S Gao; Mark E Pennesi; Christina J Flaxel; Andreas K Lauer; David J Wilson; Joachim Hornegger; James G Fujimoto; David Huang Journal: Proc Natl Acad Sci U S A Date: 2015-04-20 Impact factor: 11.205
Authors: Alice Y Kim; Zhongdi Chu; Anoush Shahidzadeh; Ruikang K Wang; Carmen A Puliafito; Amir H Kashani Journal: Invest Ophthalmol Vis Sci Date: 2016-07-01 Impact factor: 4.799
Authors: Emily S Levine; Eric M Moult; Eugenia Custo Greig; Yi Zhao; Varsha Pramil; Isaac Gendelman; Agha Y Alibhai; Caroline R Baumal; Andre J Witkin; Jay S Duker; James G Fujimoto; Nadia K Waheed Journal: Retina Date: 2022-02-01 Impact factor: 4.256